| Genetic architecture of adaptive immune system identifies key immune regulators V Lagou, JE Garcia-Perez, I Smets, L Van Horebeek, M Vandebergh, ... Cell reports 25 (3), 798-810. e6, 2018 | 46 | 2018 |
| Machine learning identifies an immunological pattern associated with multiple juvenile idiopathic arthritis subtypes E Van Nieuwenhove, V Lagou, L Van Eyck, J Dooley, U Bodenhofer, ... Annals of the rheumatic diseases 78 (5), 617-628, 2019 | 38 | 2019 |
| Genetics of multiple sclerosis: lessons from polygenicity A Goris, M Vandebergh, JL McCauley, J Saarela, C Cotsapas The Lancet Neurology 21 (9), 830-842, 2022 | 37 | 2022 |
| Effects of vitamin D and body mass index on disease risk and relapse hazard in multiple sclerosis: a Mendelian randomization study M Vandebergh, B Dubois, A Goris Neurology: Neuroimmunology & Neuroinflammation 9 (3), e1165, 2022 | 32 | 2022 |
| CHIT1 at diagnosis reflects long‐term multiple sclerosis disease activity E Oldoni, I Smets, K Mallants, M Vandebergh, L Van Horebeek, K Poesen, ... Annals of neurology 87 (4), 633-645, 2020 | 30 | 2020 |
| Locus for severity implicates CNS resilience in progression of multiple sclerosis IMSGC MultipleMS Nature 619, 323-331, 2023 | 29 | 2023 |
| Smoking and multiple sclerosis risk: a Mendelian randomization study M Vandebergh, A Goris Journal of Neurology 267 (10), 3083-3091, 2020 | 27 | 2020 |
| Environmental risk factors in multiple sclerosis: Bridging Mendelian randomization and observational studies M Vandebergh, N Degryse, B Dubois, A Goris Journal of Neurology 269 (8), 4565-4574, 2022 | 20 | 2022 |
| Body mass index, interleukin-6 signaling and multiple sclerosis: a mendelian randomization study M Vandebergh, S Becelaere, CHARGE Inflammation Working Group, ... Frontiers in immunology 13, 834644, 2022 | 18 | 2022 |
| Genetic Variation in WNT9B Increases Relapse Hazard in Multiple Sclerosis M Vandebergh, TFM Andlauer, Y Zhou, K Mallants, F Held, L Aly, ... Annals of neurology 89 (5), 884-894, 2021 | 18 | 2021 |
| Genetic basis for relapse rate in multiple sclerosis: association with LRP2 genetic variation K Hilven, M Vandebergh, I Smets, K Mallants, A Goris, B Dubois Multiple Sclerosis, 2018 | 16 | 2018 |
| Quantitative MRI phenotypes capture biological heterogeneity in multiple sclerosis patients I Smets, A Goris, M Vandebergh, J Demeestere, S Sunaert, P Dupont, ... Scientific Reports 11 (1), 1-11, 2021 | 5 | 2021 |
| Reliability and Validity of Smartphone Cognitive Testing for Frontotemporal Lobar Degeneration AM Staffaroni, AL Clark, JC Taylor, HW Heuer, M Sanderson-Cimino, ... JAMA Network Open 7 (4), e244266-e244266, 2024 | | 2024 |
| Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration R Saloner, A Staffaroni, E Dammer, ECB Johnson, E Paolillo, A Wise, ... | | 2024 |
| Genome-wide association study reveals different T cell distributions in peripheral blood of healthy individuals at high genetic risk of type 1 diabetes and long COVID CML Laura Deecke, Jan Homann, David Goldeck, Felix Luessi, Marijne ... MedRxiv, 2024 | | 2024 |
| Gene specific effects on brain volume and cognition of TMEM106B in frontotemporal lobar degeneration M Vandebergh, EM Ramos, N Corriveau-Lecavalier, VK Ramanan, ... medRxiv, 2024.04. 05.24305253, 2024 | | 2024 |
| From susceptibility to heterogeneity in multiple sclerosis: insights from genetic epidemiology M Vandebergh, A Goris, B Dubois | | 2022 |
| Chr8p23 region implicated in genetic basis for demyelination in multiple sclerosis patients I Smets, A Goris, M Moisse, M Vandebergh, V Lagou, J Demeestere, ... Multiple Sclerosis Journal 24, 387-387, 2018 | | 2018 |
Vasiliki LagouAutoimmune Genetics Laboratory, VIB, Leuven 3000, BelgiumVerified email at well.ox.ac.uk
